Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1984 1
1985 1
1986 4
1987 1
1988 2
1990 2
1991 2
1993 4
1994 4
1995 7
1996 5
1997 10
1998 7
1999 9
2000 4
2001 6
2002 7
2003 6
2004 6
2005 3
2006 3
2007 1
2008 2
2009 3
2010 2
2011 2
2012 3
2013 2
2014 2
2016 1
2017 1
2018 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Results by year

Filters applied: . Clear all
Page 1
Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer.
O'Brien ME, Wigler N, Inbar M, Rosso R, Grischke E, Santoro A, Catane R, Kieback DG, Tomczak P, Ackland SP, Orlandi F, Mellars L, Alland L, Tendler C; CAELYX Breast Cancer Study Group. O'Brien ME, et al. Among authors: kieback dg. Ann Oncol. 2004 Mar;15(3):440-9. doi: 10.1093/annonc/mdh097. Ann Oncol. 2004. PMID: 14998846 Free article. Clinical Trial.
Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2- metastatic breast cancer patients receiving palbociclib and endocrine therapy: primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial.
Harbeck N, Fasching PA, Wuerstlein R, Degenhardt T, Lüftner D, Kates RE, Schumacher J, Räth P, Hoffmann O, Lorenz R, Decker T, Reinisch M, Göhler T, Staib P, Gluz O, Schinköthe T, Schmidt M; AGO-B WSG PreCycle investigators (see Appendix 1). Harbeck N, et al. Ann Oncol. 2023 Aug;34(8):660-669. doi: 10.1016/j.annonc.2023.05.003. Epub 2023 May 16. Ann Oncol. 2023. PMID: 37201751 Free article. Clinical Trial.
Pathway-based subnetworks enable cross-disease biomarker discovery.
Haider S, Yao CQ, Sabine VS, Grzadkowski M, Stimper V, Starmans MHW, Wang J, Nguyen F, Moon NC, Lin X, Drake C, Crozier CA, Brookes CL, van de Velde CJH, Hasenburg A, Kieback DG, Markopoulos CJ, Dirix LY, Seynaeve C, Rea DW, Kasprzyk A, Lambin P, Lio' P, Bartlett JMS, Boutros PC. Haider S, et al. Among authors: kieback dg. Nat Commun. 2018 Nov 12;9(1):4746. doi: 10.1038/s41467-018-07021-3. Nat Commun. 2018. PMID: 30420699 Free PMC article.
Adnexal masses in pregnancy.
Hermans RH, Fischer DC, van der Putten HW, van de Putte G, Einzmann T, Vos MC, Kieback DG. Hermans RH, et al. Among authors: kieback dg. Onkologie. 2003 Apr;26(2):167-72. doi: 10.1159/000069838. Onkologie. 2003. PMID: 12771526
Molecular aspects of ovarian cancer. Is gene therapy the solution?
Tong XW, Kieback DG, Ramesh R, Freeman SM. Tong XW, et al. Among authors: kieback dg. Hematol Oncol Clin North Am. 1999 Feb;13(1):109-33, viii. doi: 10.1016/s0889-8588(05)70156-8. Hematol Oncol Clin North Am. 1999. PMID: 10080072 Review.
Predictive Biomarkers for Endocrine Therapy: Retrospective Study in Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial.
Roseweir AK, Bennett L, Dickson A, Cheng K, Quintayo MA, Bayani J, McMillan DC, Horgan PG, van de Velde CJH, Seynaeve C, Hasenburg A, Kieback DG, Markopoulos C, Dirix LY, Rea DW, Mallon EA, Bartlett JMS, Edwards J. Roseweir AK, et al. Among authors: kieback dg. J Natl Cancer Inst. 2018 Jun 1;110(6):616-627. doi: 10.1093/jnci/djx255. J Natl Cancer Inst. 2018. PMID: 29917140 Clinical Trial.
Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial.
van de Velde CJ, Rea D, Seynaeve C, Putter H, Hasenburg A, Vannetzel JM, Paridaens R, Markopoulos C, Hozumi Y, Hille ET, Kieback DG, Asmar L, Smeets J, Nortier JW, Hadji P, Bartlett JM, Jones SE. van de Velde CJ, et al. Among authors: kieback dg. Lancet. 2011 Jan 22;377(9762):321-31. doi: 10.1016/S0140-6736(10)62312-4. Lancet. 2011. PMID: 21247627 Clinical Trial.
Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine.
Bayani J, Yao CQ, Quintayo MA, Yan F, Haider S, D'Costa A, Brookes CL, van de Velde CJH, Hasenburg A, Kieback DG, Markopoulos C, Dirix L, Seynaeve C, Rea D, Boutros PC, Bartlett JMS. Bayani J, et al. Among authors: kieback dg. NPJ Breast Cancer. 2017 Feb 15;3:3. doi: 10.1038/s41523-016-0003-5. eCollection 2017. NPJ Breast Cancer. 2017. PMID: 28649643 Free PMC article.
115 results